Things were looking up this week for Maryland-based companies focused on health care research as two raised nearly $100 million in financing while companies in the state's medical cannabis program were blindsided by a reversal of federal policy which leaves more questions than answers and could ...
read more here
Delivered by @can_nab_is
No comments:
Post a Comment